CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes achieve insulin independence within the year, a small phase I/II study ...
Saphnelo can now be administered subcutaneously rather than intravenously following the European regulator’s recommendation.
An AI tool showed noninferiority to senior endocrinology physicians in insulin titration for hospitalized patients with type 2 diabetes. About 99% of AI-based insulin recommendations were adopted by ...
GLP-1s may confer greater protection from major adverse cardiovascular events compared with sulfonylureas, dipeptidyl-peptidase IV inhibitors and SGLT2 inhibitors in patients with type 2 diabetes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback